Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Mission Viejo, CA
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Newport Beach, CA
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Orange, CA
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Rolling Hills Estates, CA
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Aventura, FL
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Aventura, FL
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Miami, FL
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Tampa, FL
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Columbus, GA
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Columbus, GA
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Savannah, GA
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Savannah, GA
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Normal, IL
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Normal, IL
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Shiloh, IL
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Shiloh, IL
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Lenexa, KA
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Lenexa, KA
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Nicholasville, KY
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Nicholasville, KY
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
White Marsh, MD
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
White Marsh, MD
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Stevensville, MI
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Stevensville, MI
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Columbia, MO
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Columbia, MO
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Omaha, NE
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Raleigh, NC
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Cincinnati, OH
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Dayton, OH
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Oklahoma City, OK
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Medford, OR
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Medford, OR
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Pittsburgh, PA
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Charleston, SC
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Orangeburg, SC
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Austin, TX
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Dallas, TX
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Spring, TX
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Spring, TX
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
Waco, TX
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
Waco, TX
Click here to add this to my saved trials
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  11/21/2013
GSK Investigational Site
mi
from
South Burlington, VT
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 11/21/2013
GSK Investigational Site
mi
from
South Burlington, VT
Click here to add this to my saved trials
Absolute Bioavailability of Reslizumab in Healthy Subjects
A Randomized, Open-Label, Parallel-Group, Single-Dose Study to Characterize the Absolute Bioavailability of Reslizumab (220 mg) Following Subcutaneous Administration to Healthy Subjects
Status: Enrolling
Updated:  12/2/2013
Teva Investigational Site 10358
mi
from
Anaheim, CA
Absolute Bioavailability of Reslizumab in Healthy Subjects
A Randomized, Open-Label, Parallel-Group, Single-Dose Study to Characterize the Absolute Bioavailability of Reslizumab (220 mg) Following Subcutaneous Administration to Healthy Subjects
Status: Enrolling
Updated: 12/2/2013
Teva Investigational Site 10358
mi
from
Anaheim, CA
Click here to add this to my saved trials
Impact of Lung Flute Therapy on Asthma
Impact of Lung Flute Therapy on Asthma
Status: Enrolling
Updated:  12/2/2013
Buffalo General Medical Center Allergy Clinic
mi
from
Buffalo, NY
Impact of Lung Flute Therapy on Asthma
Impact of Lung Flute Therapy on Asthma
Status: Enrolling
Updated: 12/2/2013
Buffalo General Medical Center Allergy Clinic
mi
from
Buffalo, NY
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated:  12/3/2013
Novartis Investigative Site
mi
from
Huntington Beach, CA
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated: 12/3/2013
Novartis Investigative Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated:  12/3/2013
Novartis Investigative site
mi
from
Los Angeles, CA
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated: 12/3/2013
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated:  12/3/2013
Novartis Investigative Site
mi
from
Mission Viejo, CA
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated: 12/3/2013
Novartis Investigative Site
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated:  12/3/2013
Novartis Investigative Site
mi
from
Centennial, CO
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated: 12/3/2013
Novartis Investigative Site
mi
from
Centennial, CO
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated:  12/3/2013
Novartis Investigative Site
mi
from
North Dartmouth, MA
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated: 12/3/2013
Novartis Investigative Site
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated:  12/3/2013
Novartis Investigative Site
mi
from
St. Louis, MO
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated: 12/3/2013
Novartis Investigative Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated:  12/3/2013
Novartis Investigative Site
mi
from
Skillman, NJ
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated: 12/3/2013
Novartis Investigative Site
mi
from
Skillman, NJ
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated:  12/3/2013
Novartis Investigative Site
mi
from
Raleigh, NC
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated: 12/3/2013
Novartis Investigative Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated:  12/3/2013
Novartis Investigative Site
mi
from
Medford, OR
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated: 12/3/2013
Novartis Investigative Site
mi
from
Medford, OR
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated:  12/3/2013
Novartis
mi
from
Portland, OR
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated: 12/3/2013
Novartis
mi
from
Portland, OR
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated:  12/3/2013
Novartis Investigative site
mi
from
Dallas, TX
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated: 12/3/2013
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated:  12/3/2013
Novartis Investigative Site
mi
from
El Paso, TX
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma
Status: Enrolling
Updated: 12/3/2013
Novartis Investigative Site
mi
from
El Paso, TX
Click here to add this to my saved trials
AZMATICS: AZithroMycin/Asthma Trial In Community Settings
AZMATICS: Azithromycin Asthma Trial In Community Settings
Status: Enrolling
Updated:  12/11/2013
ANSR
mi
from
Peoria, IL
AZMATICS: AZithroMycin/Asthma Trial In Community Settings
AZMATICS: Azithromycin Asthma Trial In Community Settings
Status: Enrolling
Updated: 12/11/2013
ANSR
mi
from
Peoria, IL
Click here to add this to my saved trials
AZMATICS: AZithroMycin/Asthma Trial In Community Settings
AZMATICS: Azithromycin Asthma Trial In Community Settings
Status: Enrolling
Updated:  12/11/2013
AAFP National Research Network
mi
from
Kansas City, KA
AZMATICS: AZithroMycin/Asthma Trial In Community Settings
AZMATICS: Azithromycin Asthma Trial In Community Settings
Status: Enrolling
Updated: 12/11/2013
AAFP National Research Network
mi
from
Kansas City, KA
Click here to add this to my saved trials
AZMATICS: AZithroMycin/Asthma Trial In Community Settings
AZMATICS: Azithromycin Asthma Trial In Community Settings
Status: Enrolling
Updated:  12/11/2013
RAP - Cleveland Clinic
mi
from
Cleveland, OH
AZMATICS: AZithroMycin/Asthma Trial In Community Settings
AZMATICS: Azithromycin Asthma Trial In Community Settings
Status: Enrolling
Updated: 12/11/2013
RAP - Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
AZMATICS: AZithroMycin/Asthma Trial In Community Settings
AZMATICS: Azithromycin Asthma Trial In Community Settings
Status: Enrolling
Updated:  12/11/2013
University of Oklahoma Health Sciences Center (OUHSC) and Oklahoma Physicians Resource/Research Network (OKPRN)
mi
from
Oklahoma City, OK
AZMATICS: AZithroMycin/Asthma Trial In Community Settings
AZMATICS: Azithromycin Asthma Trial In Community Settings
Status: Enrolling
Updated: 12/11/2013
University of Oklahoma Health Sciences Center (OUHSC) and Oklahoma Physicians Resource/Research Network (OKPRN)
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
AZMATICS: AZithroMycin/Asthma Trial In Community Settings
AZMATICS: Azithromycin Asthma Trial In Community Settings
Status: Enrolling
Updated:  12/11/2013
Wisconsin Research and Education Network (WREN)
mi
from
Madison, WI
AZMATICS: AZithroMycin/Asthma Trial In Community Settings
AZMATICS: Azithromycin Asthma Trial In Community Settings
Status: Enrolling
Updated: 12/11/2013
Wisconsin Research and Education Network (WREN)
mi
from
Madison, WI
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
mi
from
Glendale, AZ
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
mi
from
Glendale, AZ
Click here to add this to my saved trials